Cross Cancer Institute. /ID# 252065

Edmonton, Alberta T6G 1Z2

1 studies enrolling now · 1 studies all time

What they study most

Non Small Cell Lung Cancer

Studies at this site

• A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) — Recruiting now